National Medical Care CEO Hampers makes $3.5 bil. bid for firm.
This article was originally published in The Gray Sheet
Executive SummaryNATIONAL MEDICAL CARE $3.5 BIL. TAKEOVER BID BY CEO HAMPERS will be considered by the board of directors of parent company W.R. Grace "in due course," newly named Grace President and CEO Albert Costello was reported as saying in a May 4 company release. Grace's board of directors is scheduled to meet following the company's May 10 annual stockholders meeting in Boca Raton, Florida.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.